My Healthcare News & Research — May 29, 2026 · A Silent Kidney Crisis, Now Counted

In late May 2026, a wave of coverage — including a widely shared ScienceDaily report dated May 29 and a companion news release from NYU Langone Health — drew fresh public attention to the most comprehensive global tally of chronic kidney disease in nearly a decade. The underlying study, the Global Burden of Disease (GBD) 2023 analysis of kidney disease, was published in The Lancet and led by researchers at NYU Grossman School of Medicine, the University of Glasgow, and the Institute for Health Metrics and Evaluation. Its headline is blunt: kidney disease is far more common, and rising far faster, than most people — and many clinicians — had assumed.

Table of Contents

  1. 1. What the New Report Found
  2. 2. What Chronic Kidney Disease Actually Is
  3. 3. The Numbers That Matter
  4. 4. Why It Is Rising: Sugar, Pressure, Weight
  5. 5. What This Means for You
  6. 6. Honest Caveats
  7. 7. The Takeaway
  8. Sources
  9. Connections
  10. Featured Videos

1. What the New Report Found

The GBD 2023 kidney-disease analysis estimates that about 788 million adults worldwide were living with chronic kidney disease in 2023, up from roughly 378 million in 1990. That is more than a doubling in a single generation. Expressed as a rate, an estimated 14.2% of adults — roughly one in seven — now have some degree of CKD. The report attributes about 1.48 million deaths in 2023 directly to kidney disease, which now ranks as the ninth leading cause of death globally, and it estimates that impaired kidney function contributes to roughly 11.5% of all cardiovascular deaths. A companion editorial in Nephrology Dialysis Transplantation distilled the mortality figure into a single line: one death from kidney disease roughly every 20 seconds.

It is called a “silent” crisis because most of those 788 million people feel completely well: early CKD produces no symptoms, so the large majority are undiagnosed, carrying a slowly progressing disease they do not know they have.

2. What Chronic Kidney Disease Actually Is

Your kidneys are a pair of fist-sized filters that clean waste and excess fluid from the blood while holding on to the proteins, minerals, and blood cells you need. Chronic kidney disease means that filtering capacity is permanently reduced and, usually, slowly declining. It is graded in five stages by the estimated glomerular filtration rate, or eGFR — how much blood the kidneys clean per minute — from near-normal stage 1 to stage 5 kidney failure, where dialysis or a transplant is needed to stay alive.

The catch is that the kidneys have enormous reserve: a person can lose half their filtering capacity and feel nothing. Symptoms — fatigue, swelling, foamy urine, poor appetite — tend to arrive only in later stages, when much of the damage is done. That is why a modeled global tally like this one matters: it counts the people the clinic never sees.

3. The Numbers That Matter

A few figures from the analysis are worth holding onto:

4. Why It Is Rising: Sugar, Pressure, Weight

The report is clear about what is driving the increase. The three largest attributable risk factors for kidney-disease burden are high blood sugar, high blood pressure, and high body weight — the same metabolic trio behind much of the world’s heart disease. Elevated blood glucose from type 2 diabetes damages the kidney’s delicate filtering vessels over years, a process the site covers under diabetic nephropathy. Chronically high blood pressure does parallel damage, driving hypertensive kidney disease, and rising body-mass index feeds both while adding strain of its own.

Part of the measured rise also reflects aging populations and better detection: kidney function declines naturally with age, so more people cross diagnostic thresholds simply by living longer, and more testing finds early disease that once went uncounted. Those factors do not erase the trend, but they are part of why the numbers climbed so steeply.

5. What This Means for You

The most useful thing about this report is that its main drivers are largely modifiable and testable. Chronic kidney disease is caught not by how you feel but by two cheap, routine tests that most people over 50 — and anyone with diabetes, high blood pressure, obesity, or a family history of kidney failure — should be asking their doctor about:

  1. A blood test for eGFR, calculated from serum creatinine (or, more accurately, cystatin C), which estimates how well the kidneys are filtering — see Kidney Function Tests.
  2. A urine albumin-to-creatinine ratio (uACR), which detects tiny amounts of protein leaking into the urine — often the earliest sign of damage, sometimes years before eGFR falls. See Microalbumin / ACR and Urinalysis.

Found early, progression can often be slowed dramatically. Controlling blood sugar and blood pressure, losing excess weight, staying hydrated, and moderating salt and unnecessary painkillers all help. Beyond lifestyle, a strong class of medicines has emerged in recent years — SGLT2 inhibitors, the mineralocorticoid blocker finerenone, and GLP-1 drugs such as semaglutide — that measurably slow kidney decline. The tragedy the report underlines is that these tools exist while most of the 788 million never get the simple test that would flag their disease in time to use them.

6. Honest Caveats

This is a modeled estimate, not a headcount. The Global Burden of Disease project synthesizes thousands of studies, death and treatment registries, and household surveys to fill gaps where direct data are thin. That is why every figure carries a wide uncertainty range — the 788 million estimate spans 743 to 843 million — and should be read as a careful approximation, not an exact count.

A point about dating this story, too: the peer-reviewed analysis appeared in The Lancet in November 2025; what happened in late May 2026 was a fresh round of media and institutional coverage that pushed the findings back into public view. The science is real and unchanged — but the “news” here is renewed attention to a study published several months earlier, not a brand-new result. We flag that so the timeline is transparent.

7. The Takeaway

Chronic kidney disease now touches roughly one in seven adults, kills someone about every 20 seconds, and stays invisible until it is advanced. The encouraging half of the story: its biggest causes — high blood sugar, high blood pressure, and excess weight — are already targets of ordinary preventive care, and two inexpensive tests can catch it while it is still very treatable. If you have diabetes, high blood pressure, obesity, or a family history of kidney problems, the practical action is small: ask for an eGFR blood test and a urine albumin-to-creatinine ratio at your next visit. A silent disease can only be caught by looking.

Sources

  1. GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet. 2025;406(10518):2461–2482. doi:10.1016/S0140-6736(25)01853-7 · PMID 41213283
  2. The Lancet, full text: Global, regional, and national burden of chronic kidney disease in adults, 1990–2023
  3. ScienceDaily (May 29, 2026): A silent kidney crisis is spreading far faster than experts expected
  4. Institute for Health Metrics and Evaluation (IHME) research summary: Global, regional, and national burden of chronic kidney disease in adults, 1990–2023
  5. Companion editorial: The updated global burden of chronic kidney disease: one death every 20 seconds. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag040
  6. Underlying data record: GBD 2023 Chronic Kidney Disease Estimates, 1990–2023 (GHDx)
  7. PubMed topic search: chronic kidney disease global burden GBD 2023

Connections

Back to Table of Contents